IVI and Uganda

Official Relations

In 2022, the Ministry for Science, Technology & Innovations expressed its interest in becoming a member state of IVI. In August 2022, the IVI Board of Trustees voted to approve the accession of Uganda to the IVI Establishment Agreement. 

In order to complete the accession process, the government of Uganda must deposit an instrument of accession to the IVI Establishment Agreement with the United Nations Treaty Section. 

Previous Collaboration

Regional Antimicrobial resistance Data Analysis for Advocacy, Response and Policy (RADAAR)

The RADAAR project aims to improve regional data-sharing and analysis for use in AMR planning, policy, and advocacy. Since 2021, the International Vaccine Institute (IVI), the lead grantee, has been collaborating with Brigham and Women’s Hospital (WHONET), the Big Data Institute (University of Oxford), and the Public Health Surveillance Group, as well as the Evidence-Informed Policy Network (EVIPNet) of the WHO, on various activities.

Based on identified needs and demands emerging from countries, RADAAR has laid the groundwork and embarked on a strategic pathway to strengthen the capacities of low- and middle-income countries in translating AMR knowledge (data/evidence) into effective policies. 

To this end, IVI’s Policy and Economic Research (PER) department has completed a series of training workshops and disseminated a co-developed ‘step-by-step’ AMR Policy Advocacy country guide. Furthermore, the IVI PER team conducted the RADAAR–EVIPNet country capacity strengthening pilot initiative on AMR knowledge translation, which was piloted in Bangladesh, Malawi, Nepal, and Uganda.

Cholera Research

Between 2010 and 2013, IVI’s Policy and Economic Research (PER) and Uganda’s Ministry of Health investigated the burden of cholera in Uganda and developed an investment case for Uganda to become an early adopter of oral cholera vaccines.